Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robotic System Makes Coronary Stenting Easier

By HospiMedica International staff writers
Posted on 04 Jun 2012
A remote controlled robotic system can safely and effectively guide implantation of stents during percutaneous coronary intervention (PCI) procedures, according to a new study.

Researchers at Columbia University Medical Center (New York, NY, USA), enrolled 164 patients (mean age 64, 75% male) at nine sites to the CorPath Percutaneous Robotically-Enhance Coronary Intervention Study (PRECISE) study. More...
Most of the patients had hypertension, hyperlipidemia, and a prior PCI. Lesions had to be 24 mm or less in length, able to be covered by one stent with 2 mm margins, and with a reference vessel diameter of 2.5-4 mm. The primary endpoint was clinical procedural success, defined as less than 30% residual stenosis in the target lesion at the completion of the procedure, and the absence of major adverse cardiac events (MACE) at 48 hours post index procedure or at hospital discharge, whichever occurs first.

The results showed that technical success, defined as completing a procedure without the need to convert to manual operation, was successfully completed in 98.8% of patients, without device-related complications. There were no in-hospital deaths, Q-wave myocardial infarcts (MIs), or revascularizations; however, there were four non-Q-wave MIs. At 30 days, there were no additional major adverse events. The mean robotic procedure duration was 24 minutes, mean fluoroscopy duration was 11 minutes, and the mean contrast volume used was 144 mL. The study was presented at the Society for Cardiovascular Angiography and Interventions meeting, held during May 2012 in Las Vegas (NV, USA).

“Of the 162 procedures, physicians needed to convert to manual implantation in only two instances, and the fault was not that of the robotic system,” said lead author Giora Weisz, MD. “The remote interventional cockpit also reduced operator radiation exposure by 95%.”

The CorPath 200 robotic device, a product of Corindus Vascular Robotics (Natick, MA, USA), provides procedure control for PCI procedures from an interventional cockpit, allowing precise, robotic-assisted placement of coronary guidewires and stents or balloon catheters. The physician operates in a comfortable environment, completely focused on patient physiology. The ergonomically optimized cockpit enhances visualization, minimizes fatigue, and protects the operator against exposure to radiation and other occupational hazards such as back strain from heavy lead protection aprons.

Related Links:

Columbia University Medical Center
Corindus Vascular Robotics



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.